Perioperative hypertension
Why examiners ask this
Hypertension is in almost every long stem, so the examiner uses it to test whether I can separate a number from a risk. The core questions are judgment calls: do I cancel, which home drugs do I continue, and what do I do when the pressure spikes at laryngoscopy or in recovery. It stresses application of knowledge about autoregulation and judgment about delay.
The 60-second answer
I first ask whether this is chronic, well-tolerated hypertension or a sign of something else: pain, anxiety, a full bladder, hypoxia, hypercarbia, withdrawal, pheochromocytoma or raised intracranial pressure. For elective surgery I proceed when the pressure is below 180/110 and there is no end-organ injury, because delay for moderate hypertension does not improve outcome. At or above 180/110 before the day of surgery I consider postponing elective surgery to allow gradual control,1 because these patients have labile pressures and more ischemia. I continue beta-blockers and calcium-channel blockers, and in patients taking ACE inhibitors or ARBs for controlled hypertension I hold them for 24 hours to limit intraoperative hypotension.1 Intraoperatively I blunt the response to laryngoscopy, keep the mean pressure at least 60–65 mmHg,1 and within about 20% of the patient's baseline because their autoregulation curve is shifted right, and treat spikes with short-acting titratable drugs.
Decision points and the "why"
- The 180/110 threshold — above it the risk of lability, ischemia and stroke rises, so I delay elective cases; below it I proceed. For urgent surgery I treat with short-acting agents and go ahead, because the risk of delay outweighs the risk of the pressure.
- Continue beta-blockers — withdrawal causes rebound tachycardia and ischemia; I do not start a new beta-blocker on the day of surgery, because POISE showed more stroke and death; if one is newly indicated it is started at least 8 days beforehand.1
- Hold ACE inhibitors and ARBs — they cause vasoplegia under anesthesia that responds poorly to phenylephrine; I continue them in heart failure with reduced ejection fraction when the pressure tolerates it.1
- Continue clonidine — abrupt withdrawal causes severe rebound hypertension within 18–24 hours; I switch to a patch or give the morning dose.
- Blunt laryngoscopy — the pressor response is greatest in untreated hypertensives; I use an adequate propofol dose, fentanyl 2–3 mcg/kg, esmolol 0.5–1 mg/kg or lidocaine, and limit laryngoscopy time.
- Choice of drug for a spike — first I deepen anesthesia and give analgesia, because light anesthesia is the commonest cause; then labetalol 5–10 mg, esmolol, or nicardipine or clevidipine infusions when I need tight control without slowing the heart.
- Target pressure — I hold the mean pressure near baseline rather than chase a normal number, because a chronically hypertensive brain and kidney lose perfusion at pressures a normotensive patient tolerates.
The complication they will inject
In recovery the pressure is 210/115 with a heart rate of 50 and the patient is confused. I recognize that bradycardia with hypertension is not pain; it points to raised intracranial pressure or a reflex response. I tell the surgeon, check oxygenation, CO2, glucose and pupils, and get a head CT. Alternatively the patient is awake, tachycardic and shivering with a distended bladder: I treat the cause, catheterize, give analgesia, then titrate labetalol or nicardipine to a modest reduction of about 20–25% in mean pressure over the first hour or two, because dropping it fast risks watershed ischemia.2 I reassess for ischemia with an ECG and troponin if there is chest pain or new ST changes.
Pitfalls that cost points
- Cancelling for a pressure of 160/95 in an anxious patient with no end-organ disease.
- Treating the number with a vasodilator before excluding hypoxia, hypercarbia, pain and a full bladder.
- Stopping clonidine or beta-blockers on the morning of surgery.
- Lowering a chronically hypertensive patient to "normal" and calling the resulting oliguria or confusion unexplained.
- Forgetting pheochromocytoma when hypertension is paroxysmal with headache and sweating.
Rapid-why
Q: Why is the autoregulation curve shifted right? A: Chronic hypertension thickens arteriolar walls, so the lower limit of cerebral and renal autoregulation rises and these organs need a higher pressure to stay perfused.
Q: Why esmolol for laryngoscopy? A: Onset in about a minute and a half-life of about nine minutes match the brief stimulus, so I avoid post-intubation hypotension.
Q: Why clevidipine over nitroprusside? A: It is an ultra-short-acting arterial calcium-channel blocker that does not change venous tone, is cleared by blood esterases regardless of renal or hepatic function, and avoids nitroprusside's cyanide toxicity and coronary steal;2 nitroprusside has been associated with higher mortality than the alternatives.2
Q: Why does an ARB cause refractory hypotension? A: With angiotensin blocked and sympathetic tone reduced by anesthesia, vasopressin is the remaining pressor system, so small doses of vasopressin work when phenylephrine fails.
Numbers to know
| Item | Value |
|---|---|
| Consider delaying elective surgery | ≥180/110 mmHg1 |
| Intraoperative target | MAP ≥60–65 mmHg or SBP ≥90,1 and within ~20% of baseline |
| Hypertensive emergency | Lower MAP 20–25% over 1–2 h2 |
| Labetalol | 5–20 mg IV, repeat every 10 min |
| Esmolol bolus | 0.5–1 mg/kg IV |
| Nicardipine infusion | 5–15 mg/h |
| Clevidipine infusion | 1–2 mg/h start, double every 90 s |
| Hold ACE inhibitor or ARB | 24 h before surgery (continue in HFrEF)1 |
Links
- Preoperative cardiac evaluation for non-cardiac surgery, Perioperative myocardial ischemia and infarction, Intraoperative hypotension: differential and management, pheochromocytoma, Vasopressors and inotropes: choosing and titrating
- ACC/AHA Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery (2024)
- ACC/AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
Sources
- 1.2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What's new? · Cleveland Clinic Journal of Medicine, 2025 · ccjm.orgCohn SL, CCJM 92(4), April 2025. Review of the 2024 AHA/ACC guideline; the primary guideline text (ahajournals/jacc) was not reachable from the fetcher.
- 2.Hypertensive Emergencies · Merck Manual Professional Edition · merckmanuals.com
Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.